HAE
Price
$116.19
Change
-$0.93 (-0.79%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
5.33B
14 days until earnings call
Intraday BUY SELL Signals
SRTS
Price
$2.87
Change
+$0.01 (+0.35%)
Updated
Oct 22 closing price
Capitalization
47.25M
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HAE vs SRTS

HAE vs SRTS Comparison Chart in %
View a ticker or compare two or three
VS
HAE vs. SRTS commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HAE is a Hold and SRTS is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for HAE with price predictions
Oct 22, 2026

HAE sees MACD Histogram just turned negative

HAE saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 22, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 41 instances where the indicator turned negative. In 29 of the 41 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for HAE moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 28 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 59 cases where HAE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 63%.

The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HAE as a result. In 44 of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HAE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

HAE broke above its upper Bollinger Band on October 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a +0.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where HAE advanced for three days, in 235 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

The Aroon Indicator entered an Uptrend today. In 160 of 209 cases where HAE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. HAE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 48 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 66 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.365) is normal, around the industry mean (2.874). P/E Ratio (56.303) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (1.676) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (3.668) is also within normal values, averaging (40.124).

A.I.Advisor
a Summary for SRTS with price predictions
Oct 22, 2026

SRTS in downward trend: price dove below 50-day moving average on September 18, 2026

SRTS moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend. In 33 of 39 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SRTS as a result. In 79 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

The 10-day moving average for SRTS crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

The Aroon Indicator for SRTS entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SRTS's RSI Indicator exited the oversold zone, 27 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 53 cases where SRTS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

Following a +4.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRTS advanced for three days, in 226 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

SRTS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.282) is normal, around the industry mean (2.874). P/E Ratio (-3.053) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (2.874) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. SRTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
HAE vs SRTS: Fundamental Ratings
HAE
SRTS
OUTLOOK RATING
1..100
7077
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
48100
SMR RATING
1..100
6697
PRICE GROWTH RATING
1..100
3572
P/E GROWTH RATING
1..100
231
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRTS's Valuation (29) in the Medical Specialties industry is somewhat better than the same rating for HAE (91). This means that SRTS’s stock grew somewhat faster than HAE’s over the last 12 months.

HAE's Profit vs Risk Rating (48) in the Medical Specialties industry is somewhat better than the same rating for SRTS (100). This means that HAE’s stock grew somewhat faster than SRTS’s over the last 12 months.

HAE's SMR Rating (66) in the Medical Specialties industry is in the same range as SRTS (97). This means that HAE’s stock grew similarly to SRTS’s over the last 12 months.

HAE's Price Growth Rating (35) in the Medical Specialties industry is somewhat better than the same rating for SRTS (72). This means that HAE’s stock grew somewhat faster than SRTS’s over the last 12 months.

HAE's P/E Growth Rating (2) in the Medical Specialties industry is in the same range as SRTS (31). This means that HAE’s stock grew similarly to SRTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HAESRTS
RSI
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
71%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 24 days ago
69%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
84%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (HAE: $117.11 vs. SRTS: $2.87)
Brand notoriety: HAE and SRTS are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: HAE: 117% vs. SRTS: 43%
Market capitalization -- HAE: $5.33B vs. SRTS: $47.25M
HAE [@Medical/Nursing Services] is valued at $5.33B. SRTS’s [@Medical/Nursing Services] market capitalization is $47.25M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HAE’s FA Score shows that 1 FA rating(s) are green while SRTS’s FA Score has 2 green FA rating(s).

  • HAE’s FA Score: 1 green, 4 red.
  • SRTS’s FA Score: 2 green, 3 red.
According to our system of comparison, HAE is a better buy in the long-term than SRTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HAE’s TA Score shows that 4 TA indicator(s) are bullish while SRTS’s TA Score has 4 bullish TA indicator(s).

  • HAE’s TA Score: 4 bullish, 4 bearish.
  • SRTS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, HAE is a better buy in the short-term than SRTS.

Price Growth

HAE (@Medical/Nursing Services) experienced а -3.30% price change this week, while SRTS (@Medical/Nursing Services) price change was +3.61% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

HAE is expected to report earnings on Nov 05, 2026.

SRTS is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
HAE
Daily Signal:
Gain/Loss:
SRTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

HAE and

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with SRTS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then SRTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
-0.81%
SRTS - HAE
44%
Loosely correlated
+0.35%
ECOR - HAE
43%
Loosely correlated
+0.82%
ATR - HAE
41%
Loosely correlated
+1.97%
PEN - HAE
41%
Loosely correlated
+0.43%
GH - HAE
39%
Loosely correlated
-2.23%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SAY25.300.03
+0.12%
Saratoga Investment Corp
DHDG37.82-0.22
-0.58%
FT Vest U.S. Equity Quarterly 2.5 to 15 Buffer ETF (DHDG)
AOD10.11-0.14
-1.37%
abrdn Total Dynamic Dividend Fund
ACV23.81-0.34
-1.41%
Virtus Diversified Income & Convertible Fund
CIFU2.18-0.49
-18.50%
T-REX 2X Long CIFR Daily Target ETF (CIFU)